CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (CTMX)

Q: What does CUSIP 23284F105 represent in this 13F holders report?

CUSIP 23284F105 is the security identifier for CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share in Q2 2022?

86 institutional investors reported CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 23284F105

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.00001 per share
Shares outstanding: 217,291,620
Total 13F shares: 45,579,430
Share change: -7,947,264
Total reported value: $83,410,352
Put/Call ratio: 0%
Price per share: $1.83
Number of holders: 86
Value change: -$17,825,825
Number of buys: 43
Number of sells: 64

Quarterly Holders Quick Answers

What is CUSIP 23284F105?
CUSIP 23284F105 identifies CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 23284F105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BVF INC/IL	13F	Company	2.7%	5,803,700	$15,496,000	—	31 Mar 2022	13F
RTW INVESTMENTS, LP	13F	Company	2.7%	5,779,700	$15,432,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	2.4%	5,222,886	$13,945,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	2.3%	4,992,094	$13,328,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	2%	4,371,300	$11,671,000	—	31 Mar 2022	13F
Rubric Capital Management LP	13F	Company	1.1%	2,406,449	$6,425,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1%	2,245,190	$5,995,000	—	31 Mar 2022	13F
ORBIMED ADVISORS LLC	13F	Company	0.98%	2,124,975	$5,674,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.92%	2,000,000	$5,340,000	—	31 Mar 2022	13F
S.c.a. Candriam	13F	Individual	0.76%	1,653,878	$4,416,000	—	31 Mar 2022	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.59%	1,290,600	$3,446,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.55%	1,198,682	$3,200,000	—	31 Mar 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.49%	1,075,110	$2,871,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.48%	1,050,148	$2,803,000	—	31 Mar 2022	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.45%	980,085	$2,617,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.41%	895,900	$2,392,000	—	31 Mar 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.41%	885,107	$2,362,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.37%	809,140	$2,161,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.35%	758,589	$2,026,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	0.32%	701,804	$1,874,000	—	31 Mar 2022	13F
Altium Capital Management LLC	13F	Company	0.31%	663,800	$1,772,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.3%	661,063	$1,765,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.26%	573,435	$1,531,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.23%	491,776	$1,313,000	—	31 Mar 2022	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.16%	353,115	$943,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.16%	348,300	$930,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.14%	305,032	$814,000	—	31 Mar 2022	13F
AXA S.A.	13F	Company	0.11%	242,100	$646,407	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.09%	200,943	$621,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.1%	212,293	$567,000	—	31 Mar 2022	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.09%	200,199	$535,000	—	31 Mar 2022	13F
Clearline Capital LP	13F	Company	0.09%	190,600	$509,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.08%	169,951	$454,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.08%	167,178	$447,000	—	31 Mar 2022	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.08%	162,997	$435,000	—	31 Mar 2022	13F
PDT Partners, LLC	13F	Company	0.06%	138,123	$369,000	—	31 Mar 2022	13F
XTX Topco Ltd	13F	Company	0.05%	118,339	$316,000	—	31 Mar 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.05%	114,005	$304,000	—	31 Mar 2022	13F
STRS OHIO	13F	Company	0.05%	106,900	$285,000	—	31 Mar 2022	13F
Squarepoint Ops LLC	13F	Company	0.05%	106,761	$285,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.04%	87,671	$234,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	85,231	$228,000	—	31 Mar 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.04%	85,379	$227,000	—	31 Mar 2022	13F
Private Advisor Group, LLC	13F	Company	0.04%	84,179	$224,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	81,801	$218,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.04%	77,619	$206,000	—	31 Mar 2022	13F
GLOBEFLEX CAPITAL L P	13F	Company	0.03%	69,435	$185,000	—	31 Mar 2022	13F
HRT FINANCIAL LP	13F	Company	0.03%	68,259	$182,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	67,376	$180,000	—	31 Mar 2022	13F
ALPS ADVISORS INC	13F	Company	0.03%	67,211	$179,000	—	31 Mar 2022	13F

Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (CTMX) as of Q2 2022

As of 30 Jun 2022, CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (CTMX) was held by 86 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,579,430 shares. The largest 10 holders included BVF INC/IL, VANGUARD GROUP INC, RTW INVESTMENTS, LP, Point72 Asset Management, L.P., Rubric Capital Management LP, ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., and Candriam S.C.A.. This page lists 87 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

112

Q2 2022 holders

Holder diff

-26

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.